医学临床研究
  2025年5月1日 星期四           首 页    |    期刊简介    |    编委会    |    投稿指南    |    期刊订阅    |    广告合作    |    留言板    |    联系我们    |    English
医学临床研究  2020, Vol. 37 Issue (2): 189-192    DOI: 10.3969/j.issn.1671-7171.2020.02.009
  论著 本期目录 | 过刊浏览 | 高级检索 |
非酒精性脂肪肝合并2型糖尿病患者的肝脏脂肪含量与各代谢指标的相关性
王思超a, 孙卫霞a, 成艺坪a, 侯琳a, 王蕾b, 赵萌a, 马世瞻a, 陈青a, 李秋a, 景斐a, 邵珊珊a, 管庆波a, 周新丽a
山东大学附属省立医院:a.内分泌科;b.超声诊疗科, 山东 济南 250021
Correlation between Liver Fat Content and Metabolic Indexes in Patients with Non-alcoholic Fatty Liver Complicated with Type 2 Diabetes
WANG Si-chao, SUN Wei-xia, CHENG Yi-ping,et al
Department of Endocrinology, Department of Ultrasonic Diagnosis and Treatment, Shandong Provincial Hospital affiliated to Shandong University,Jinan, Shandong 250021, China
全文: PDF (0 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 【目的】探讨超声定量检测2型糖尿病(T2DM)合并非酒精性脂肪肝(NAFLD)患者肝脏脂肪含量(LFC),并分析其与各代谢指标的相关性。【方法】选取T2DM合并NAFLD患者105例(观察组),另选无脂肪肝的单纯T2DM患者43例(对照组)。采用计算机辅助超声定量LFC,全自动生化分析仪检测各代谢指标血尿酸(SUA)、谷丙转氨酶(ALT)、谷草转氨酶(AST)、总胆固醇(TC)、三酰甘油(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、血尿素氮(BUN)、游离脂肪酸(FFA)、糖化血红蛋白(HbA1C)、空腹血糖(FPG) 、空腹胰岛素(FINS) 、尿微量白蛋白(ALB)、尿肌酐(CREA),计算胰岛素抵抗指数(HOMA-IR = FPG×FINS/22.5)。比较两组各代谢指标的差异并分析LFC与各指标的相关性。【结果】观察组ALT、TG、LDL-C、FPG、CREA、HOMA-IR水平、LFC均高于对照组, HDL-C水平低于对照组,其差异有统计学意义(P<0.05)。相关性分析显示:观察组中LFC与ALT、TG呈正相关;对照组中LFC与ALT、AST、TG呈正相关(P<0.05)。【结论】NAFLD作为T2DM的常见并发症,应用超声定量测定 LFC ,操作简单、成本低廉、无创便捷,可反映肝功血脂等相关指标变化,可作为入院常规筛检手段,为早期发现肝脏脂肪样变提供依据。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
关键词 糖尿病,2型/并发症脂肪肝/并发症    
Abstract【Objective】To evaluate the application of quantitative measurement of liver fat content (LFC) in patients with nonalcoholic fatty liver disease(NAFLD)complicated with type 2 diabetes mellitus(T2DM)by ultrasound, and to explore the correlation between quantitative results and metabolic indexes.【Methods】A total of 105 patients with NAFLD complicated with T2DM were selected as the observation group, and 43 T2DM patients without fatty liver disease were enrolled as the control group. The FLC was estimated by computer assisted ultrasound. Fully automatic biochemical analyzer detected various metabolic indexes such as serum uric acid (SUA), glutamic acid transaminase (ALT), aspartate aminotransferase (AST), total cholesterol (TC), triacylglycerol (TG), high-density lipoprotein cholesterol (HDL-C), Low-density lipoprotein cholesterol (LDL-C), blood urea nitrogen (BUN), free fatty acids (FFA), glycated hemoglobin (HbA1C), fasting blood glucose (FPG), fasting insulin (FINS), urine microalbumin (ALB ) and Urine creatinine (CREA). Insulin resistance index was calculated (HOMA-IR = FPG × FINS / 22.5). The differences in metabolic indexes between the two groups were compared and the correlation between LFC and each index was analyzed.【Results】The levels of ALT, TG, LDL-C, FPG, CREA, HOMA-IR, and LFC in the observation group were higher than those in the control group, while the level of HDL-C was lower than that in the control group; the differences were statistically significant (P<0.05). Correlation analysis showed that LFC was positively correlated with ALT and TG in the observation group; and LFC was positively correlated with ALT, AST, and TG in the control group (P<0.05).【Conclusion】 As a common complication of T2DM, NAFLD is used to quantitatively determine LFC by ultrasound. It is simple, low-cost, non-invasive and convenient, and can reflect changes in related indexes such as liver function and lipids. It can be used as a routine screening method for admission and provide a basis for early detection of liver fatty changes.
Key wordsDiabetes Mellitus,Type 2/CO    Fatty Liver/CO
收稿日期: 2019-04-15     
PACS:  R587.1  
基金资助:山东省重点研发计划(2017GSF18129);国家重点研发计划(2017YFC1309805)
通讯作者: E-mail:zhouxinli0301@163.com   
引用本文:   
王思超, 孙卫霞, 成艺坪, 侯琳, 王蕾, 赵萌, 马世瞻, 陈青, 李秋, 景斐, 邵珊珊, 管庆波, 周新丽. 非酒精性脂肪肝合并2型糖尿病患者的肝脏脂肪含量与各代谢指标的相关性[J]. 医学临床研究, 2020, 37(2): 189-192.
WANG Si-chao, SUN Wei-xia, CHENG Yi-ping,et al. Correlation between Liver Fat Content and Metabolic Indexes in Patients with Non-alcoholic Fatty Liver Complicated with Type 2 Diabetes. JOURNAL OF CLINICAL RESEARCH, 2020, 37(2): 189-192.
链接本文:  
http://journal07.magtech.org.cn/yxlcyj/CN/10.3969/j.issn.1671-7171.2020.02.009     或     http://journal07.magtech.org.cn/yxlcyj/CN/Y2020/V37/I2/189
版权所有 © 2013 医学临床研究杂志社  湘ICP备13012052号-1
办公地址:湖南省长沙市芙蓉区新军路43号煤炭大院主办公楼6楼621、623、632、636室 邮编:410011 电话(传真):0731-84824007 E-mail:jcr_cs.hn@vip.163.com
技术支持:北京玛格泰克科技发展有限公司 技术支持:support@magtech.com.cn